Skeptic Ginger
Nasty Woman
- Joined
- Feb 14, 2005
- Messages
- 96,955
Has inserting a furin cleavage site (FCS) into SARS-like CoVs been done and if so what happened? The point of this post is to document it was possible Shi and Daszak, being top virologists studying SARS-like CoVs, certainly had the capability of inserting those 12 nucleotides of the FCS into a SARS-like CoV and it wouldn't necessarily be detectable. And yes, I am repeating stuff already discussed in the thread as the evidence coalesces.
2022 The Emergence of the Spike Furin Cleavage Site in SARS-CoV-2; Yujia Alina Chan (1) and Shing Hei Zhan (2)
2022 The Emergence of the Spike Furin Cleavage Site in SARS-CoV-2; Yujia Alina Chan (1) and Shing Hei Zhan (2)
So it wasn't a novel technique to insert an FCS into a SARS-like CoV.Focusing on CoVs, several groups have shown that introducing a cleavage site to enable promiscuous cleavage of the spike by different proteases can boost viral entry in different cell types. ...
... That same year, another group of scientists manipulated the S1/S2 FCS and a second cleavage site in the spikes of MERS-CoV and a MERS-related virus to show that these could enable the MERS-related CoV spike to become activated by human proteases and mediate viral entry into human cells (Yang et al. 2015). Scientists have also been introducing FCSs into the spike of SARS-CoV to gain a better understanding of how an additional FCS can alter membrane fusion and reliance on cellular proteases (Follis et al. 2006; Belouzard et al. 2009).
The Difficulty of Determining the Origin of the SARS-CoV-2 FCS
Jack Nunberg, whose group first inserted an S1/S2 FCS into the spike of SARS-CoV, said: “there is no way to know whether humans or nature inserted the site” in SARS-CoV-2 (Cyranoski 2020). ...
A group led by Gary Whittaker later showed that a substitution was sufficient when combined with the introduction of another FCS at the S2 region; this experiment in SARS-CoV was inspired by the observation of a similar setup in IBV strain Beaudette, which has efficient cleavage at both S1/S2 and S2’ (Belouzard et al. 2009). Whittaker recently (August 2021) published a comment describing the SARS-CoV-2 FCS as “highly unusual” (Whittaker 2021).
In September 2021, it was reported that an international group of scientists (including from the Wuhan Institute of Virology) had, in March 2018, proposed a roadmap for detecting novel proteolytic cleavage sites (including FCSs) in the spike sequences of novel sarbecoviruses and inserting these novel cleavage sites into the appropriate parental strain (Daszak 2018; Lerner and Hibbett 2021).
The virologist David Baltimore commented that “these features make a powerful challenge to the idea of a natural origin for SARS2,” later clarifying that “you can't distinguish between the two origins from just looking at the sequence” (Caltech Weekly 2021).
I certainly don't deny this despite it's been missed by some reading my posts. The problem is, if the origin could be natural or from a lab one has to then look at the other evidence.Therefore, an S1/S2 FCS emerging in a sarbecovirus is consistent with natural evolution. ...
... Even so, the knowledge that scientists had a workflow for identifying novel cleavage sites in diverse SARSr-CoVs and experimentally characterizing these cleavage sites in SARSr-CoVs—likely in a manner that makes the resulting recombinant SARSr-CoV practically indistinguishable from a rare SARSr-CoV with a naturally emerging FCS—makes it challenging to rule out an artificial origin of the SARS-CoV-2 S1/S2 FCS (Daszak 2018; Lerner and Hibbett 2021).
